ClinicalTrials.gg
Drug

Ganciclovir clinical trials

Also written Zirgan and Cytovene.

Includes 76 studies of Valganciclovir.

studies test it
139
open now
8
in phase 3
34
first study started
1990

How each study uses Ganciclovir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ganciclovir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Jun 1989 · CYTOVENE · NDA 019661 (FDA, Drugs@FDA)
European Union
18 Mar 1997 · Vitrasert Implant · EMEA/H/C/000120 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ganciclovir
58
Ganciclovir (GCV)
3
Cymeven®
2
IV Ganciclovir
2

Brand

Zirgan
2
Cytovene
2

Studies by the year they started

104 studies that test it; most in 2004 (8)

Studies that test Ganciclovir, by start year
YearStudies
19901
19911
19921
19941
19972
19991
20005
20014
20023
20034
20048
20055
20067
20071
20084
20093
20102
20116
20127
20132
20143
20154
20162
20171
20184
20193
20203
20214
20221
20231
20245
20252
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
28
Phase 2
36
Phase 3
34
Phase 4
19
No phase
30

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 36 · Other 103

National Institute of Allergy and Infectious Diseases (NIAID) (23) · Hoffmann-La Roche (22) · University of California, San Francisco (4) · Viracta Therapeutics, Inc. (3) · Fred Hutchinson Cancer Center (3) · Roche Global Development (3) · National Cancer Institute (NCI) (2) · Dr. Ann C.T.M. Vossen (2)

Often tested with

Tested in the same studies.

Foscarnet (5) · Zidovudine (4) · Acyclovir (4) · Bortezomib (3) · Sirolimus (3) · Nanatinostat (3) · Mycophenolic Acid (3) · Prednisone (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Ganciclovir is the comparator. A study of two new drugs counts under both.

  • 2Letermovir · Hospital do Rim e Hipertensão, Columbia University · next primary completion Jan 2028
Reaching primary completion within a year · 5

Studies that test Ganciclovir.

Studies

Open first, then newest update. How each study uses Ganciclovir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 139

See all 139 studies that test Ganciclovir →

Given beside what is tested · 13 — Ganciclovir is usual care or a partner of the new treatment
As the comparator · 12 — what is tested is compared with Ganciclovir

Codes

What other systems call Ganciclovir · ClinicalTrials.gg INT008500

  • MeSH (NLM) D015774GanciclovirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) P9G3CKZ4P5GANCICLOVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 4678Confirmed FDA, Wikidata
  • Wikidata Q417640ganciclovirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C517GanciclovirOne source FDA
  • DrugBank DB01004One source Wikidata

Also registered as ganciclovir sodium (UNII 02L083W284 · RxNorm 82131).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.